Price (delayed)
$11.86
Market cap
$321.65M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.53
Enterprise value
$105.19M
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™
There are no recent dividends present for ARCT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.